Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

FBIO Fortress Biotech Inc

-0.05 (-2.67%)
Last Updated: 11:22:53
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Fortress Biotech Inc FBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -2.67% 1.82 11:22:53
Open Price Low Price High Price Close Price Prev Close
1.89 1.79 1.94 1.87
more quote information »

Recent News

Date Time Source Heading
5/16/202408:30GLOBEAvenue Therapeutics Announces Last Patient Last Visit in..
5/16/202408:00GLOBEFortress Biotech to Participate in the Alliance Global..
5/15/202416:15GLOBEFortress Biotech Reports First Quarter 2024 Financial..
5/15/202416:01GLOBEJourney Medical Corporation to Participate in the Alliance..
5/15/202408:30GLOBEAvenue Therapeutics Reports First Quarter 2024 Financial..
5/14/202408:30GLOBEFortress Biotech Announces First Patient Dosed in..
5/13/202416:01GLOBEJourney Medical Corporation Reports First Quarter 2024..
5/07/202408:30GLOBEJourney Medical Corporation to Announce First Quarter 2024..
5/02/202416:01GLOBEMustang Bio Announces Closing of $4 Million Public Offering
5/01/202416:01GLOBEJourney Medical Corporation Appoints Joseph Benesch as Chief..
4/29/202420:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
4/29/202408:00GLOBEAvenue Therapeutics Announces Exercise of Warrants for $4.4..
4/25/202408:30GLOBEJourney Medical Corporation to Present at the Planet..
4/24/202407:30GLOBEAvenue Therapeutics Announces Reverse Stock Split
3/28/202416:05GLOBEFortress Biotech Reports 2023 Financial Results and Recent..
3/28/202409:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
3/25/202408:30GLOBEAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL)..
3/21/202416:01GLOBEJourney Medical Corporation Reports Full-Year 2023 Financial..
3/18/202416:05GLOBEAvenue Therapeutics Reports Full Year 2023 Financial Results..
3/18/202408:30GLOBEJourney Medical Corporation Announces U.S. FDA Acceptance of..
3/15/202408:30GLOBEJourney Medical Corporation to Announce Year End 2023..
3/15/202408:15GLOBEAvenue Therapeutics Receives Positive Listing Determination..
3/13/202408:30GLOBEJourney Medical Corporation to Participate in the 36th..
3/12/202408:30GLOBEFortress Biotech to Participate in 36th Annual ROTH..
3/11/202408:30GLOBEJourney Medical Corporation Announces Presentation of Data..
3/11/202408:00GLOBEAvenue Therapeutics to Present BAER-101 Preclinical Data at..
3/07/202407:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
3/04/202408:30GLOBEFortress Biotech and Cyprium Therapeutics Announce $4.1..
2/22/202408:30GLOBEAvenue Therapeutics Announces Publication in Drug..
1/11/202408:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
1/11/202408:00GLOBEAvenue Therapeutics to Present at Sidoti January Micro-Cap..
1/05/202409:15GLOBEAvenue Therapeutics Enters into Warrant Exercise..
1/05/202408:30GLOBEJourney Medical Corporation Submits New Drug Application to..
1/04/202408:30GLOBEAvenue Therapeutics Reaches Final Agreement with the U.S...
1/03/202416:01GLOBEFortress Biotech Announces Closing of $11 Million Registered..
1/02/202416:05GLOBEJourney Medical Corporation Secures Credit Facility with SWK..
1/02/202408:30GLOBEAvenue Therapeutics Announces Completion of Enrollment in..
12/29/202308:20GLOBEFortress Biotech Announces Pricing of $11 Million Registered..
12/11/202308:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
12/06/202308:30GLOBECyprium Therapeutics, a Fortress Biotech Subsidiary Company,..
12/06/202308:30PRNUSSentynl Therapeutics Completes Asset Transfer of CUTX-101..
12/06/202308:00GLOBEJourney Medical Corporation Announces Successful Completion..
12/01/202308:30GLOBEAvenue Therapeutics to Present at American Epilepsy Society..
11/14/202316:10GLOBEFortress Biotech Reports Third Quarter 2023 Financial..
11/14/202316:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
11/14/202316:01GLOBEFortress Biotech Announces Closing of $10.0 Million Public..
11/13/202316:05GLOBEAvenue Therapeutics Reports Third Quarter 2023 Financial..
11/10/202308:15GLOBEFortress Biotech Announces Pricing of $10.0 Million Public..
11/09/202317:05GLOBEFortress Biotech Announces Launch of Proposed Public..
11/07/202316:01GLOBEJourney Medical Corporation Reports Third Quarter 2023..

Your Recent History

Delayed Upgrade Clock